Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio
Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background
RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio.
Immuno-oncology …